Skip to main content
. Author manuscript; available in PMC: 2017 Jul 27.
Published in final edited form as: Drugs. 2012 Aug 20;72(12):1617–1630. doi: 10.2165/11633140-000000000-00000

Table 2.

Medications Associated with the Development of Atrial Fibrillation

Drug Group Quality of Evidence Drugs
Cardiovascular High Acetylcholine, adenosinea, dobutaminea
Moderate Flecainide,b milrinone, propafenoneb
Low Amiodarone, atenolol, digoxin, diltiazem, dopamine, dopexamine, isosorbide mononitrate, levosimendan, losartan, nesiritide, thiazide diuretics, verapamil
Respiratory High Aminophylline/theophylline
Moderate --
Low Albuterol, arformoterol, corticosteroids, fluticasone, ipratropium, methylprednisolonea, pseudoephedrine, salmeterol
Antineoplastic High --
Moderate Amifostine, cisplatin,a interleukin-2, melphalana
Low Cyclophosphamide, docetaxel, doxorubicin, 5-fluorouracil, gemcitabinea, interferon-α, lenalidomide, mitoxantrone, paclitaxel
CNS agents High --
Moderate --
Low Atropine, apomorphinea, clozapine, fluoxetine, lacosamide, olanzapine, physostigminea, sumatriptan,a tranylcypromine, trazodone
Genitourinary High --
Moderate --
Low Sildenafil, vardenafil
Miscellaneous High Alcoholc
Moderate --
Low Azathioprineb, anabolic steroidsa, bisphosphonates, caffeine, etanercept, nicotine, pentagastrin
a

Medications reported in van der Hooft, 2004[5] with further evidence documented after 2004.

b

Atrial flutter

c

Predominantly alcohol binging

H = High; L = Low; M = Moderate